Jiangsu Nhwa Pharmaceutical Co.,Ltd.’s Net Profit Rose 9.7% in First Three Quarters of 2022

Jiangsu Nhwa Pharmaceutical Co.,Ltd. (江苏恩华药业股份有限公司) (002262.SZ) reported a net profit of 735.9 million yuan in the first three quarters of 2022, up 9.7% year-on-year.

Meanwhile, the company posted 3.1 billion yuan in revenue, up 7.9% year-on-year.

At the end of the reporting period, it had 6.2 billion yuan in total assets and 807.5 million yuan in total liabilities, with a liability-to-asset ratio of 12.9%.